1. Immune Checkpoint Blockade Therapy for Breast Cancer: Lessons from Epithelial–Mesenchymal Transition
    Isabel O’Connell et al, 2023, Molecular Diagnosis & Therapy CrossRef
  2. Comparative expression analysis of immune-related markers in surgically resected lung neuroendocrine neoplasms
    Bence Ferencz et al, 2023, Lung Cancer CrossRef
  3. Targeting Myeloid Checkpoint Molecules in Combination With Antibody Therapy: A Novel Anti-Cancer Strategy With IgA Antibodies?
    Chilam Chan et al, 2022, Frontiers in Immunology CrossRef
  4. Tumoral and paratumoral NK cells and CD8+ T cells of esophageal carcinoma patients express high levels of CD47
    Zuzana Strizova et al, 2020, Scientific Reports CrossRef
  5. Nanoscale Coordination Polymers for Combined Chemotherapy and Photodynamic Therapy of Metastatic Cancer
    Youyou Li et al, 2021, Bioconjugate Chemistry CrossRef
  6. HX009, a novel BsAb dual targeting PD1 x CD47, demonstrates potent anti-lymphoma activity in preclinical models
    Hang Ke et al, 2023, Scientific Reports CrossRef
  7. The Crosstalk Between Tumor Cells and the Immune Microenvironment in Breast Cancer: Implications for Immunotherapy
    Vincenzo Salemme et al, 2021, Frontiers in Oncology CrossRef
  8. Clinicopathological and Prognostic Significance of CD47 Expression in Lung Neuroendocrine Tumors
    Mario Orozco-Morales et al, 2021, Journal of Immunology Research CrossRef
  9. Green Synthesized Honokiol Transfersomes Relieve the Immunosuppressive and Stem-Like Cell Characteristics of the Aggressive B16F10 Melanoma
    Yasmeen Ezzeldeen et al, 2021, International Journal of Nanomedicine CrossRef
  10. Quantum Dot-Based Dual-Color In Situ Fluorescence Imaging of the Coevolution of CD68 and CD47 in Breast Cancer
    Xue-Hui Shi et al, 2022, ACS Applied Nano Materials CrossRef
  11. Canadine Platinum(IV) Complexes Targeting Epithelial–Mesenchymal Transition as Antiproliferative and Antimetastatic Agents
    Yan Chen et al, 2024, Journal of Medicinal Chemistry CrossRef
  12. CD47-SIRPαAxis as a Biomarker and Therapeutic Target in Cancer: Current Perspectives and Future Challenges in Nonsmall Cell Lung Cancer
    Rodrigo Catalán et al, 2020, Journal of Immunology Research CrossRef
  13. Role of CD47 in tumor immunity: a potential target for combination therapy
    Jing Huang et al, 2022, Scientific Reports CrossRef
  14. Expression of CD47 in Endometrial Cancer and Its Clinicopathological Significance
    Mei Yang et al, 2022, Journal of Oncology CrossRef
  15. Targeting CD47 as a Novel Immunotherapy for Breast Cancer
    Can Chen et al, 2022, Frontiers in Oncology CrossRef

  16. CD47 Overexpression Is Associated with Epstein–Barr Virus Infection and Poor Prognosis in Patients with Nasopharyngeal Carcinoma


    Zhi-Hui Wang et al, 2020, OncoTargets and Therapy CrossRef